chr4-83305540-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001098540.3(HPSE):c.1206+663A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.694 in 152,058 control chromosomes in the GnomAD database, including 37,251 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.69 ( 37251 hom., cov: 32)
Consequence
HPSE
NM_001098540.3 intron
NM_001098540.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.55
Publications
1 publications found
Genes affected
HPSE (HGNC:5164): (heparanase) Heparan sulfate proteoglycans are major components of the basement membrane and extracellular matrix. The protein encoded by this gene is an enzyme that cleaves heparan sulfate proteoglycans to permit cell movement through remodeling of the extracellular matrix. In addition, this cleavage can release bioactive molecules from the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.795 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HPSE | NM_001098540.3 | c.1206+663A>C | intron_variant | Intron 9 of 11 | ENST00000311412.10 | NP_001092010.1 | ||
| HPSE | NM_006665.6 | c.1206+663A>C | intron_variant | Intron 10 of 12 | NP_006656.2 | |||
| HPSE | NM_001199830.1 | c.1032+663A>C | intron_variant | Intron 8 of 10 | NP_001186759.1 | |||
| HPSE | NM_001166498.3 | c.985-3272A>C | intron_variant | Intron 8 of 10 | NP_001159970.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.694 AC: 105490AN: 151940Hom.: 37235 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
105490
AN:
151940
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.694 AC: 105552AN: 152058Hom.: 37251 Cov.: 32 AF XY: 0.699 AC XY: 51989AN XY: 74334 show subpopulations
GnomAD4 genome
AF:
AC:
105552
AN:
152058
Hom.:
Cov.:
32
AF XY:
AC XY:
51989
AN XY:
74334
show subpopulations
African (AFR)
AF:
AC:
23078
AN:
41434
American (AMR)
AF:
AC:
11107
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
2646
AN:
3472
East Asian (EAS)
AF:
AC:
4228
AN:
5182
South Asian (SAS)
AF:
AC:
3867
AN:
4828
European-Finnish (FIN)
AF:
AC:
8118
AN:
10570
Middle Eastern (MID)
AF:
AC:
210
AN:
294
European-Non Finnish (NFE)
AF:
AC:
50191
AN:
67980
Other (OTH)
AF:
AC:
1513
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1616
3232
4847
6463
8079
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
826
1652
2478
3304
4130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2821
AN:
3474
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.